第一作者机构:[1]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Hematol, Beijing, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhao Shi-Hua,Zhu Zun-Min,Yang Tao,et al.Rituximab, high-dose methotrexate plus orelabrutinib as induction therapy in newly diagnosed primary central nervous system lymphoma[J].LEUKEMIA.2025,doi:10.1038/s41375-025-02658-8.
APA:
Zhao, Shi-Hua,Zhu, Zun-Min,Yang, Tao,Gao, Da,Liu, Li-Hong...&Huang, Wen-Rong.(2025).Rituximab, high-dose methotrexate plus orelabrutinib as induction therapy in newly diagnosed primary central nervous system lymphoma.LEUKEMIA,,
MLA:
Zhao, Shi-Hua,et al."Rituximab, high-dose methotrexate plus orelabrutinib as induction therapy in newly diagnosed primary central nervous system lymphoma".LEUKEMIA .(2025)